전남대학교 중앙도서관

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

학술저널

issue: In The Lancet Oncology April 2021 22(4):476-488
Author: Piccart, Martine ^{*, *}
van 't Veer, Laura J ^*
Poncet, Coralie ^*
Lopes Cardozo, Josephine M N
Delaloge, Suzette
Pierga, Jean-Yves
Vuylsteke, Peter
Brain, Etienne
Vrijaldenhoven, Suzan
Neijenhuis, Peter A
Causeret, Sylvian
Smilde, Tineke J
Viale, Giuseppe
Glas, Annuska M
Delorenzi, Mauro
Sotiriou, Christos
Rubio, Isabel T
Kümmel, Sherko
Zoppoli, Gabriele
Thompson, Alastair M
Matos, Erika
Zaman, Khalil
Hilbers, Florentine
Fumagalli, Debora
Ravdin, Peter
Knox, Susan
Tryfonidis, Konstantinos
Peric, Aleksandra
Meulemans, Bart
Bogaerts, Jan
Cardoso, Fatima
Rutgers, Emiel J T
DB Label: Database : ScienceDirect

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.

학술저널

issue: Journal of Clinical Oncology (J CLIN ONCOL), 4/20/2022; 40(12): 1335-1345. (11p)
Author: Lopes Cardozo, Josephine M N; ^1,2Drukker, Caroline A; ¹Rutgers, Emiel J T; ¹Schmidt, Marjanka K; ³Glas, Annuska M; ⁴Witteveen, Anke; ⁴Cardoso, Fatima; ⁵Piccart, Martine; ⁶Esserman, Laura J; ⁷Poncet, Coralie; ²van 't Veer, Laura J⁸
DB Label: Database : CINAHL Plus with Full Text

원문보기: 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort.

학술저널

issue: Breast (Edinburgh, Scotland) [Breast] 2023 Oct; Vol. 71, pp. 143-149. Date of Electronic Publication: 2023 May 18.
Author: Lopes Cardozo JMN; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Emmanuel Mounier 83/11, 1200, Brussels, Belgium.
Veira SE; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Ait Hassou L; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Emmanuel Mounier 83/11, 1200, Brussels, Belgium.
Uwimana AL; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Emmanuel Mounier 83/11, 1200, Brussels, Belgium.
Božović-Spasojević I; Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia.
Bogaerts J; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Emmanuel Mounier 83/11, 1200, Brussels, Belgium.
Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Av. Brasília, 1400-038, Lisbon, Portugal.
Schmidt MK; Department of Molecular Pathology and Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Rutgers EJT; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Poncet C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Avenue Emmanuel Mounier 83/11, 1200, Brussels, Belgium.
Drukker CA; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands. Electronic address: c.drukker@nki.nl.
DB Label: Database : MEDLINE

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) Open Access (PubMed Central) Full Text (ScienceDirect O/A) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.

학술저널

issue: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Apr 01; Vol. 41 (10), pp. 1849-1863. Date of Electronic Publication: 2023 Jan 23.
Author: Lopes Cardozo JMN; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Eccles DM; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Fasching PA; Department of Gynecology and Obstetricss, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Rutgers EJT; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
van 't Veer LJ; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
DB Label: Database : MEDLINE

원문보기: 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

바구니보기

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택